These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs]. Ackermann E Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493 [No Abstract] [Full Text] [Related]
3. [Unforseeable hazards of various drugs]. Laroche C; Simon P; Fraisse B Munch Med Wochenschr; 1972 Sep; 114(38):1595-9. PubMed ID: 4678409 [No Abstract] [Full Text] [Related]
4. [Clinical and toxicological significance of toxicity mechanisms]. Gillmann H Arzneimittelforschung; 1977; 27(96):1819-20. PubMed ID: 579146 [No Abstract] [Full Text] [Related]
5. Effect upon drug toxicity of surgical interference with hepatic or renal function. Selye H; Mécs I Acta Hepatogastroenterol (Stuttg); 1974 Aug; 21(4):266-73. PubMed ID: 4450984 [No Abstract] [Full Text] [Related]
6. Effect of diet on the metabolism and toxicology of drugs. Ioannides C; Parke DV J Hum Nutr; 1979 Oct; 33(5):357-66. PubMed ID: 115915 [TBL] [Abstract][Full Text] [Related]
7. [Unforeseeable dangers of some drugs]. Lareche C; Simon P; Fraisse B Minerva Med; 1973 Mar; 64(17):880-4. PubMed ID: 4703859 [No Abstract] [Full Text] [Related]
8. Clinical pharmacological aspects of drug toxicity testing. Ackermann E Pol J Pharmacol Pharm; 1980; 32(2):237-41. PubMed ID: 7454628 [TBL] [Abstract][Full Text] [Related]
9. The effect of hepatic metabolism on the production and toxicity of reactive metabolites in extrahepatic organs. Boyd MR; Statham CN Drug Metab Rev; 1983; 14(1):35-47. PubMed ID: 6839941 [No Abstract] [Full Text] [Related]
10. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Spielberg SP Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group. World Health Organ Tech Rep Ser; 1975; (563):1-59. PubMed ID: 803745 [No Abstract] [Full Text] [Related]
12. Preventing drug toxicity in renal failure. DiPalma JR RN; 1975 Jun; 38(6):65-9. PubMed ID: 1039792 [No Abstract] [Full Text] [Related]
13. Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations. Drayer DE Drugs; 1982 Dec; 24(6):519-42. PubMed ID: 6759093 [No Abstract] [Full Text] [Related]
14. Drug metabolism: an industrial research view of the future. Ober RE Drug Metab Rev; 1979; 10(2):315-9. PubMed ID: 551917 [No Abstract] [Full Text] [Related]
15. Effects of modifying structure on electrophilic reactions with biological nucleophiles. Coles B Drug Metab Rev; 1984-1985; 15(7):1307-34. PubMed ID: 6398776 [No Abstract] [Full Text] [Related]
16. Research in the Division of Toxicology. The importance of reactive intermediates of drug biotransformation in drug toxicity. Mulder GJ Pharm Weekbl Sci; 1985 Apr; 7(2):67-70. PubMed ID: 4000901 [TBL] [Abstract][Full Text] [Related]
17. Lethal drug interactions. Martin EW Tex Med; 1973 Jan; 69(1):39-55. PubMed ID: 4631428 [No Abstract] [Full Text] [Related]
19. [Metabolism of drugs and drug security]. Rentsch GA Dtsch Med Wochenschr; 1975 Oct; 100(44):2285-92. PubMed ID: 1183328 [No Abstract] [Full Text] [Related]
20. Monitoring drug-protein interaction. Yang XX; Hu ZP; Chan SY; Zhou SF Clin Chim Acta; 2006 Mar; 365(1-2):9-29. PubMed ID: 16199025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]